US 12,662,664 B2Granted

Modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses

AssigneePharmact Holding AG

InventorsGunther Burgard, Rainer Boehnke, Sven Benson, Lenz Lorenz, Philipp Schellenberger

Life of this patent

Estimating the term…

Abstract

Disclosed is a modified bacterial hyaluronidase polypeptide, a production process thereof, and a pharmaceutical composition containing the modified bacterial hyaluronidase polypeptide, and its uses.

Claims11

Dependent claims

A modified bacterial hyaluronidase polypeptide consisting of SEQ ID No. 1.

Dependencies are inferred from the claim text.

Facts

Application: 17/920,348Filed 20 Apr 2020
Published: US 2023/0167428 A11 Jun 2023
Granted: 23 Jun 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C12N 9/2474
Hydrolysing O- and S- glycosyl compounds: hyaluronoglucosaminidase , i.e. hyaluronidase
C12N 9/88
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes: lyases
C12N 15/70
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression: vectors or expression systems…
C12Y 402/02001
Acting on polysaccharides: hyaluronate lyase

Family

US 2023/0167428 A1Pre-grant publication · published 1 Jun 2023
US 12,662,664 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results